South San Francisco, CA (March 28, 2018) – Today, the Damon Runyon Cancer Research Foundation (Damon Runyon) held the seventh annual Accelerating Cancer Cures Research Symposium.
Media Room--We can provide journalists with expert commentary on topics like:
- Challenges facing early career scientists, and new technologies and trends in cancer research (all forms of cancer)
- Connections to bright, articulate early career scientists involved in leading-edge cancer research projects
- Introductions to scientists and doctors nationwide, and interviews with our President and CEO, Board Members, or others
Contact: Yung S. Lie, PhD, President and CEO, yung.lie@damonrunyon.org, 212.455.0521
Press releases are listed below. Visit New Discoveries for breakthroughs from our scientists.
Mission: To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. The Foundation supports emerging leaders who have great potential to achieve breakthroughs in how we diagnose, treat and prevent cancer. Since its founding in 1946, the Foundation has invested nearly $450 million and funded 4,000 young scientists. 100% of all donations to the Foundation are used to support scientific research.
March 28, 2018
Industry and Academic Researchers Gather for Innovative Accelerating Cancer Cures Research Symposium
February 5, 2018
The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named 15 new Damon Runyon Fellows at its fall Fellowship Award Committee review. The recipients of this prestigious, four-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. The Committee also named six new recipients of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists.
January 23, 2018
The Damon Runyon Cancer Research Foundation announced that ten scientists with innovative approaches have been named 2018 recipients of the Damon Runyon-Rachleff Innovation Award. Five initial grants were awarded to support projects that have the potential to significantly impact cancer. In addition, continued “Stage 2” support (two more years of funding) was granted to five awardees who demonstrated significant progress on their research during the first two years of the award.
July 26, 2017
New York, NY (July 26, 2017) – The Damon Runyon Cancer Research Foundation has named four outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Fellowship Award, committing nearly $1 million to help address a critical shortage of funding for pediatric cancer research.
July 14, 2017
The Damon Runyon Cancer Research Foundation named 18 new Damon Runyon Fellows at its spring Fellowship Award Committee review. The recipients of this prestigious, four-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. The Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding to work on innovative projects that have the potential to impact cancer prevention, diagnosis, and treatment.
July 3, 2017
The Damon Runyon Cancer Research Foundation named five new Damon Runyon Clinical Investigators at its spring 2017 Clinical Investigator Award Committee review. The recipients of this prestigious three-year award are outstanding early career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation’s leading scientists and clinicians. The Foundation also awarded Continuation Grants to three Damon Runyon Clinical Investigators. The Continuation Grant is designed to support Clinical Investigators who are approaching the end of their original awards and need extra time and funding to complete a promising avenue of research or initiate/continue a clinical trial.
June 30, 2017
To help increase the number of physician-scientists, the Damon Runyon Cancer Research Foundation has created the new Damon Runyon Physician-Scientist Training Award, which provides physicians who have earned an MD degree and completed clinical specialty fellowship training the opportunity to gain the research experience they need to become leaders in translational and clinical research. Damon Runyon announced that four scientists with novel approaches to fighting cancer have been named the 2017 recipients of the award.
May 24, 2017
BRONX, New York – May 24, 2017 – On Saturday, July 15, 2017, the Damon Runyon Cancer Research Foundation will hold the 9th Annual Runyon 5K at Yankee Stadium – and 100 percent of funds raised will directly support innovative cancer research by brilliant, early career scientists.
May 23, 2017
SAN FRANCISCO – May 17, 2017 – The Damon Runyon Cancer Research Foundation hosted a benefit performance of the Broadway musical HAMILTON on Tuesday, May 16, 2017, at the SHN Orpheum Theatre in San Francisco, raising almost $1 million for innovative cancer research.
March 6, 2017
Industry and Academic Researchers Gather for Innovative Accelerating Cancer Cures Research Symposium
Today, the Damon Runyon Cancer Research Foundation held the sixth annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer. Hosted this year by Novartis, the meeting included academic researchers from top universities and research institutions as well as scientists from Celgene, Eli Lilly and Company, Genentech, Merck, and Novartis.
